Adma Biologics | ADMA - Cash And Equivalent

Stock Price
16.61
Daily Change
-0.92 -5.22%
Monthly
-7.90%
Yearly
-1.57%
Q1 Forecast
16.77

Adma Biologics reported $61.38M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Adma Biologics USD 61.38M 28.9M Sep/2025
Alnylam Pharmaceuticals USD 1.49B 376.56M Sep/2025
Dynavax Technologies USD 160.25M 61.15M Sep/2025
Takeda JPY 654.94B 26.55B Dec/2025